Michael Novogratz
Angel Investor
New York, United States
Michael Novogratz is a seed investor in New York focused on FinTech and Blockchain. Michael E. Novogratz is based out of New York, New York, and is the Founder and CEO of Galaxy Digital. Michael previously served at Partner and President of Fortress Investment Group. Michael E. Novogratz attended Princeton University.
- Total investments:
- 11
- Last investment:
- Lead investor:
- 18%
Last updated:
For AI agents: llms.txt
Industries Michael Novogratz invests in
Stages Michael Novogratz invests in
Countries Michael Novogratz invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Seed
- $1.1M–$8.5M
- Series A
- $11M–$26M
- Series B
- $60M–$150M
Investment Focus
Industry
- FinTech 3 (27%)
- Blockchain 3 (27%)
- Financial Services 3 (27%)
- Internet 2 (18%)
- Health Care 2 (18%)
Stage
- Seed 5 (45%)
- Series A 2 (18%)
- Series B 2 (18%)
- Post-IPO Equity 1 (9%)
- Convertible Note 1 (9%)
Country
- United States 6 (55%)
- India 1 (9%)
- Germany 1 (9%)
- Nigeria 1 (9%)
- South Korea 1 (9%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Curative provides employer-based health insurance plans and healthcare services. The company delivers a plan with no copays, no deductibles, and a fixed monthly premium, aiming to make medical care easier to access and manage. It offers preventive care including an annual baseline visit, behavioral health services, primary and specialty care,prescription drug coverage, and integration with a network of providers. Curative also supports virtual care through its telehealth offering, enabling members to consult clinicians remotely for common health issues. Previously, the company was involved in large-scale diagnostic testing and vaccine distribution during the COVID-19 pandemic, and has since shifted focus to its insurance and care management services. | $150M / Series B / Nov 28, 2025 | ||
| Mansa develops a streaming platform featuring black culture. They are removing obstacles and integrating all formats. With tales from all over the world, they're displaying both fresh talent and seasoned pros. With their "Watch Out Loud Feature," they're linking viewers with one another, and with Web3 features, they'll beconnecting creators with their audiences. | $8M / Seed / Apr 18, 2023 | ||
| Verandah uses artisanal fabrics and hand embroidery from India for its luxury resort label. | $1.1M / Seed / Dec 23, 2021 | ||
| Alerzo is a B2B e-commerce retail company providing a technology and services platform that transforms how informal retail stores operate. It offers on-demand inventory distribution and financial services for small informal stores while also providing real-time market trends, customer feedback, and other consumer purchasing data to brands andmanufacturers.The company was founded in 2019 and is based in Ibadan, Nigeria. | $10.5M / Series A / Aug 20, 2021 | ||
| CryptoQuant is a community-driven analytics platform to lower hurdles of data-based decisions. Crypto investors often fail to make data-based decisions due to a lack of time and knowledge. We lower the hurdles of data-based decisions by saving research time and decreasing the knowledge gap. | $3M / Seed / Aug 11, 2021 | ||
| Portal is a financial services company that trades crypto anywhere without putting coins at risk, all from within a controllable wallet. Founded in 2018, Portal is headquartered in San Francisco, California. | $8.5M / Seed / Jun 01, 2021 | ||
| Cambrian Biopharma is building the medicines that will modernize healthcare in the 21st century – therapeutics to lengthen healthspan, the period of life spent in good health.As a Distributed Development Company (or DisCo), Cambrian is advancing multiple scientific breakthroughs, each targeting a biological driver of aging. Our approach is todevelop interventions that treat specific diseases first, then deploy them as preventative medicines to improve quality of life/overall quality of life as we age. | $60M / Series B / Feb 09, 2021 | ||
| ATAI is a global biotech company builder that leverages a decentralized, technology- and data-driven platform model to serve millions of people suffering from mental health disorders. The company is committed to acquiring and efficiently developing innovative treatments that address significant unmet medical needs and lead to paradigm shifts in themental health space.ATAI Life Sciences was founded in 2018 and is based in Munich, Bayern, Germany. | $25M / Convertible Note / Apr 27, 2020 | ||
| Galaxy Digital operates as a technology-driven financial services and investment management firm that provides institutions and direct clients with a full suite of financial solutions spanning the digital assets ecosystem. Galaxy Digital operates five synergistic business lines: Trading, Asset Management, Principal Investments, Investment Banking,and Mining. | $5M / Post-IPO Equity / Jan 02, 2019 | ||
| ATAI is a global biotech company builder that leverages a decentralized, technology- and data-driven platform model to serve millions of people suffering from mental health disorders. The company is committed to acquiring and efficiently developing innovative treatments that address significant unmet medical needs and lead to paradigm shifts in themental health space.ATAI Life Sciences was founded in 2018 and is based in Munich, Bayern, Germany. | $25.5M / Series A / Oct 03, 2018 | ||
| See all 11 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Michael Novogratz invest in?
Michael Novogratz invests primarily in FinTech, Blockchain and Financial Services startups, most often at Seed and Series A stage. Most of the 11 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Michael Novogratz's check size?
Michael Novogratz typically joins rounds of $1.1M–$8.5M at Seed, $11M–$26M at Series A and $60M–$150M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Michael Novogratz participates in.
How do I contact Michael Novogratz?
Public channels for Michael Novogratz include LinkedIn and X (Twitter). For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Michael Novogratz last invest?
The most recent investment recorded for Michael Novogratz closed in Nov 2025. Shizune tracks 11 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
